Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Morning Bell 13 October

Grady Wulff
October 13, 2022

Closing Bell 12 October

Grady Wulff
October 12, 2022

Morning Bell 12 October

Grady Wulff
October 12, 2022

Closing Bell 11 October

Grady Wulff
October 11, 2022

Morning Bell 11 October

Grady Wulff
October 11, 2022

Closing Bell 10 October

Grady Wulff
October 10, 2022

Morning Bell 10 October

Sophia Mavridis
October 10, 2022

Weekly Wrap 7 October

Grady Wulff
October 7, 2022

Closing Bell 6 October

Grady Wulff
October 6, 2022

Morning Bell 6 October

Grady Wulff
October 6, 2022

Closing Bell 5 October

Grady Wulff
October 5, 2022

Morning Bell 5 October

Grady Wulff
October 5, 2022